Testing a culturally adapted treatment for substance use disorders in American Indian communities
Official title: Randomized Controlled Trial of Indigenous Recovery Planning for American Indians
Funded at Montana State University - Bozeman · NIH-11042779 · Data updated 2026-11-12
This study is working to help American Indians at the Fort Peck Indian Reservation who are dealing with substance use issues by testing a special program designed just for their community, with local members leading the way to make sure it fits their needs.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Montana State University - Bozeman NIH-funded |
| Lab location | 1 site (Bozeman, United States) |
| Project start | April 1, 2021 |
| Project end | February 28, 2026 |
| Funding year | 2025 |
| Award (this year) | $639,129 |
| NIH project number | 5R01DA053791-05 |
| Project ID | NIH-11042779 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are American Indian individuals aged 21 and older who are experiencing substance use disorders.
✕Less likely to help
Patients who do not identify as American Indian or who are under 21 years old may not receive benefit from this research.
What this research studies
This research aims to address the high rates of substance use disorders among American Indians by testing a culturally adapted relapse prevention intervention. The study employs a Community-Based Participatory Research approach, collaborating with community partners from the Fort Peck Indian Reservation to develop and deliver the intervention. Trained community members will implement the program, which has been tailored to meet the specific cultural needs and challenges faced by the community. The goal is to improve health equity and provide effective treatment options for individuals struggling with substance use disorders.
Why it matters
Potential benefit: If successful, this research could provide culturally relevant and effective treatment options for American Indians facing substance use disorders.
How similar studies have gone: Other research has shown success with culturally adapted interventions for substance use disorders, indicating potential for positive outcomes in this study.
Where this research is happening
-
Montana State University - Bozeman
Bozeman, United States Active
Researchers
- Principal investigator: Skewes, Monica C — Montana State University - Bozeman
- Study coordinator: Skewes, Monica C
Related research
Other NIH-funded projects on the same topics.
-
Cognitive behavioral therapy and trazodone for insomnia phenotypes with high blood pressure
A clinical study tests how CBT-I and the sleep drug trazodone work for adults with insomnia and high blood pressure, focusing on a specific sleep duration pattern.
-
Shorter antifungal treatment for kids with candidemia
A multi-center pediatric trial tests whether a shorter, 7 extra days of antifungal therapy after an initial 7 days is just as good as the standard 14-day approach for kids with candidemia who are improving on echinocandin therapy.
-
Short Course vs Standard Course Antifungal Therapy for Pediatric Candidemia
This study tests whether a shorter 7-day total antifungal treatment after an initial 7 days of echinocandin therapy is as effective as the usual 14-day course for children with candidemia.
-
Shorter antifungal treatment for kids with candidemia
A multi-center study tests whether kids with candidemia can finish treatment earlier after an initial week of antifungal therapy than the standard two weeks total.
-
Shorter antifungal treatment for kids with candidemia
This study tests whether children with candidemia can finish treatment after 7 days of an echinocandin if they are improving, instead of completing a full 14 days.
-
Shorter antifungal course for kids with candidemia
A multi-center study tests whether 7 extra days of antifungal therapy after an initial week of treatment can be shortened safely for children with candidemia.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.